- Home
- AUTL vs BHK Comparison
AUTL vs BHK Comparison
Compare AUTL & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | BHK |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.6M | 679.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | BHK |
|---|---|---|
| Price | $1.57 | $9.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 188.3K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $51,128,000.00 | N/A |
| Revenue This Year | $658.11 | N/A |
| Revenue Next Year | $91.34 | N/A |
| P/E Ratio | ★ N/A | $10.42 |
| Revenue Growth | ★ 406.67 | N/A |
| 52 Week Low | $1.11 | $9.02 |
| 52 Week High | $2.80 | $11.09 |
Technical Indicators
Market Signals| Indicator | AUTL | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 56.48 | 48.61 |
| Support Level | $1.46 | $9.46 |
| Resistance Level | $1.69 | $9.52 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 73.33 | 59.52 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.